Fenoldopamin in der Herzchirurgie

Translated title of the contribution: Fenoldopamin in cardiac surgery

G. Landoni, D. Poli, T. Bove

Research output: Contribution to journalArticlepeer-review


Fenoldopam mesylate is a useful antihypertensive and diuretic drug. In this review, we examine the evidence based medicine wheter to use fenoldopam in cardiac surgery patients and/or in critically ill patients with or at risk for acute renal failure (ARF). We conclude that from published studies it seems that fenoldopam could be beneficial if a prolonged infusion is performed starting early in the process of ARF in critically ill patients. Unfortunately there is still virtually no definitive evidence of efficacy, especially in cardiac surgery patients. A large, multicenter, randomized, controlled trial (RCT) is needed to confirm the promising but conflicting findings of this drug.

Translated title of the contributionFenoldopamin in cardiac surgery
Original languageGerman
JournalClinical Research in Cardiology Supplements
Issue numberSUPL.1
Publication statusPublished - 2007


  • acute renal failure
  • cardiac surgery
  • diuretics
  • fenoldopam
  • renal replacement therapy

ASJC Scopus subject areas

  • Molecular Biology
  • Radiology Nuclear Medicine and imaging
  • Structural Biology


Dive into the research topics of 'Fenoldopamin in cardiac surgery'. Together they form a unique fingerprint.

Cite this